{"id":"NCT00088530","sponsor":"CTI BioPharma","briefTitle":"BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)","officialTitle":"Pixantrone (BBR 2778) Versus Other Chemotherapeutic Agents for Third-line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma: A Randomized, Controlled, Phase III Comparative Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-07","primaryCompletion":"2010-02","completion":"2010-07","firstPosted":"2004-07-29","resultsPosted":"2017-06-01","lastUpdate":"2020-02-05"},"enrollment":140,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma, Non-Hodgkin"],"interventions":[{"type":"DRUG","name":"pixantrone, cyclophosphamide, vincristine, rituximab, prednisone","otherNames":["BBR2778"]},{"type":"DRUG","name":"Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab","otherNames":[]}],"arms":[{"label":"Experimental Arm","type":"EXPERIMENTAL"},{"label":"Comparator Arm","type":"ACTIVE_COMPARATOR"}],"summary":"BBR 2778 is a novel aza-anthracenedione that has activity in experimental tumors and shows reduced potential for cardiotoxicity in animal models. This cytotoxic agent has structural similarities with mitoxantrone as well as general similarities with anthracyclines (such as the tricyclic central quinoid chromophore).","primaryOutcome":{"measure":"Complete Response (CR) and Complete Response Unconfirmed (CRu)","timeFrame":"EOT; approximately 6 months","effectByArm":[{"arm":"Experimental Group","deltaMin":20,"sd":null},{"arm":"Comparator Group","deltaMin":5.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":99,"countries":["United States","Argentina","Bulgaria","Costa Rica","Ecuador","Estonia","France","Germany","Hungary","India","Italy","Mexico","Panama","Peru","Poland","Romania","Russia","Ukraine","United Kingdom","Uruguay"]},"refs":{"pmids":["22652183"],"seeAlso":["http://www.celltherapeutics.com"]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":68},"commonTop":["Neutropenia","Anemia","Pyrexia","Thrombocytopenia","Asthenia"]}}